RecruitingNCT06224530
Single-dose levetiracetam and brain activity in people at risk of psychosis
About this title
Read the official source — NCT06224530Medication studyAges 18–40United KingdomSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 40 years.
- Listed locations
- LondonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 19, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 69
- Sponsor
- King's College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United Kingdom
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT06224530
- Official title
Show the full official title
Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is King's College London, a university.
Does this study involve medication?
Yes. The study involves medication, including Levetiracetam and Placebo.
Who can participate?
Listed age limits: 18 years to 40 years.
Is this study still recruiting?
The registry lists this study as recruiting.
